EUVIMEDEUVIMED entdecken
Crossref

Cycloastragenol Regulates Mitochondrial Homeostasis–Mediated Renal Tubular Injury to Ameliorate Diabetic Kidney Disease by Directly Targeting ERK to Modulate TFEB

Gai Gao, Zhiwen Liu, Hui Wang, Pan Wang, Shuyan Liu, Ruidi Liu, Yanrao Wu, Zhenzhen Wang, Jiangyan Xu, Zhenqiang Zhang iD, Xiaowei Zhang, Zhishen Xie iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Gai Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine, Henan Province, Henan University of Ch…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Diabetic Nephropathies, Mitochondria, Kidney Tubules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Special Research Project of Henan Province on Traditional chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Restoring mitochondrial homeostasis to inhibit apoptosis in renal tubular epithelial cells (RTECs) has emerged as a promising therapeutic strategy for diabetic kidney disease (DKD). This study focuses on the therapeutic effect and mechanism of the triterpenoid compound cycloastragenol (CAG) from Astragali Radix in the treatment of DKD. Experimental Procedure The DKD model was established in C57BL/6J db/db mice and AGEs‐induced HK‐2 cells. Various biological techniques such as WB and RT‐PCR revealed that CAG enhanced mitophagy via TFEB, reducing apoptosis in RTECs. Mechanistic studies combining CETSA, molecular docking, and molecular dynamics simulations confirmed the CAG‐ERK interaction. Key Results CAG improved renal function and reduced renal tubular injury in db/db mice. CAG effectively reduced the accumulation of mitoROS, enhanced mitochondrial membrane potential, promoted mitophagy and mitochondrial biogenesis, and restored mitochondrial homeostasis. Mechanistically, CAG enhanced mitophagy in db/db mice and AGEs‐induced HK‐2 cells by stimulating the autophagic flux via regulating TFEB. Moreover, CAG inhibited AGEs‐induced HK‐2 apoptosis, which was reversed by autophagy inhibitor chloroquine (CQ) and siRNA‐TFEB. Importantly, after mutating the valine (VAL) at position 39 of the ERK to alanine (ALA), the binding effect between CAG and ERK was significantly reduced, revealing that CAG directly bound ERK at 39VAL, inhibiting its phosphorylation, thus preventing the phosphorylation of the S142 site of TFEB and enabling TFEB to translocate into the nucleus. Conclusions and Implications CAG ameliorated renal tubule damage in DKD by regulating mitochondrial quality though targeting ERK to regulate TFEB. This research advances drug development and proposes lifestyle interventions (e.g., dietary supplements).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsDiabetic NephropathiesMitochondriaKidney TubulesTriterpenesExtracellular Signal-Regulated MAP KinasesAnimalsMice, Inbred C57BLMiceHumansMaleMitophagyCell LineApoptosisHomeostasisAutophagyMembrane Potential, MitochondrialMolecular Docking Simulation

Stichwörter der Autor:innen

ERK/TFEBapoptosiscycloastragenoldiabetic kidney diseasemitophagy

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTcfeb protein, mouseTriterpenesTFEB protein, humanExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine, Henan Province, Henan University of Chinese Medicine, Zhengzhou, China.
  • Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou, China.
  • The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

ORCID-Profile: Zhenqiang Zhang, Zhishen Xie

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Special Research Project of Henan Province on Traditional chinese Medicine
  • Henan Provincial Key Research and Development Program
  • Henan provincial science and technology research and development program joint fund
  • Chinese Medicine International Cooperation Project (Base Project)
  • Program for Innovation Talent (in Science and Technology) in the University of Henan Province

Zitieren

APA

Gao, G., Liu, Z., Wang, H., Wang, P., Liu, S., Liu, R., Wu, Y., Wang, Z., Xu, J., Zhang, Z., Zhang, X., & Xie, Z. (2026). Cycloastragenol Regulates Mitochondrial Homeostasis–Mediated Renal Tubular Injury to Ameliorate Diabetic Kidney Disease by Directly Targeting ERK to Modulate TFEB. Phytotherapy Research. https://doi.org/10.1002/ptr.70136

Vancouver

Gao G, Liu Z, Wang H, Wang P, Liu S, Liu R, et al. Cycloastragenol Regulates Mitochondrial Homeostasis–Mediated Renal Tubular Injury to Ameliorate Diabetic Kidney Disease by Directly Targeting ERK to Modulate TFEB. Phytotherapy Research. 2026. doi:10.1002/ptr.70136

BibTeX
@article{Gao2026,
  author = {Gao, Gai and Liu, Zhiwen and Wang, Hui and Wang, Pan and Liu, Shuyan and Liu, Ruidi and Wu, Yanrao and Wang, Zhenzhen and Xu, Jiangyan and Zhang, Zhenqiang and Zhang, Xiaowei and Xie, Zhishen},
  title = {Cycloastragenol Regulates Mitochondrial Homeostasis–Mediated Renal Tubular Injury to Ameliorate Diabetic Kidney Disease by Directly Targeting ERK to Modulate TFEB},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70136}
}
Kostenlos starten →